Mundipharma and CorMedix have announced a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in patients receiving allogeneic hematopoietic stem cell transplants. More: Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win Source: fierce
read moreEleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer and its ATTR competitor BridgeBio, analysts say. More: Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts Source: fierce
read moreHaleon, a healthcare consumer and OTC brand company, has hired Richard Manso, a Google veteran, as its new U.S. chief marketing officer. More: Haleon nabs Google exec Richard Manso as US chief marketing officer Source: fierce
read moreCompared with a 5.3% increase in Xtandi sales to $6 billion in fiscal year 2025, Astellas expects the star prostate cancer drug’s revenue to drop by 5.3% during fiscal 2026. More: Astellas counts on new medicines to offset projected Xtandi
read moreAlready the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition of women’s health leader Organon. With its $11.75 billion buyout, Sun has picked up a drugmaker that matched the $6.2 billion in
read more
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants More: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals